
A healthcare management professional, Dr Olumuyiwa Olusanya, has called for an urgent shift in Nigeria’s healthcare system towards prioritising diagnostics and preventive care, warning that the current approach of treating illnesses only after they occur is inefficient and costly.
Olusanya, a member of the International Society for Pharmacoeconomics and Outcomes Research, made the call at a webinar recently organised by SYNLAB.
Speaking on the topic “Financing Beyond Treatment: Covering Prevention, Diagnostics and Continuity of Care,” he lamented that healthcare in Nigeria and across Africa has long been centred on treatment rather than early detection and prevention.
“For a long time, healthcare financing in Nigeria, and indeed Africa, has been synonymous with paying for treatment after people have fallen ill. Today, we must reimagine a system where we finance the full spectrum of care, from prevention to treatment,” he said.
Olusanya, who is the managing partner, founder and chief executive officer of Insignia Health, emphasised that diagnostics remain central to effective healthcare delivery. He cited the World Health Organisation (WHO), which estimates that about 65 per cent of all clinical decisions are based on diagnostic results.
“That means that, to practise evidence-based medicine effectively, significant investment must be made in diagnostics to determine the appropriate treatment for patients,” he said.
Despite this, he noted that diagnostics and preventive care are not adequately integrated into Nigeria’s healthcare system or financing structures.
“We need to ask ourselves whether prevention and diagnostics are embedded in our healthcare financing. That is critical. Most benefit packages, whether social or private, are heavily treatment-focused, with little emphasis on prevention,” he added.
The healthcare management expert explained that this gap often leads to late detection of diseases, significantly increasing the cost and complexity of treatment.
Highlighting the economics of early detection, he noted that conditions such as breast cancer, diabetes, hypertension, and cervical cancer become far more expensive to manage when diagnosed late.
“When you look at the data, you see how costs escalate to catastrophic levels without early detection. For breast cancer, costs can rise by as much as 8.5 times; diabetes, about six times; hypertension, five times; and cervical cancer, nearly ten times,” he said.
According to him, integrating preventive care and diagnostics into healthcare systems would not only improve health outcomes but also reduce the long-term financial burden on individuals and the healthcare system.
“We need to incorporate preventive health checks and diagnostic testing into healthcare financing packages, whether through private or social health insurance,” he said.
Olusanya further advocated mandatory screenings and structured diagnostic packages within health plans, including age- and gender-specific tests.
“One way to achieve this is to ensure that mandatory health screenings and diagnostic packages are built into insurance plans. Annual screenings and targeted diagnostics should form part of standard entitlements,” he added.
He also proposed that a portion of health insurance premiums be specifically allocated to diagnostics and prevention.
“We can ring-fence about 15 to 20 per cent of premiums to fund preventive care through diagnostics,” he said, adding that incentives could be introduced to encourage compliance.
“We can offer lower premiums for high screening compliance, encouraging people to undertake annual medical checks and manage their health risks proactively,” the expert said.
He stressed that diagnostic service providers also have a critical role to play in strengthening preventive care.
“Diagnostics providers must develop affordable screening packages in partnership with health schemes and expand access to testing at the community level,” he said.
Olusanya also highlighted the importance of continuity of care, noting that preventive efforts must extend beyond initial screening to include follow-up and monitoring.
“We must ensure post-treatment monitoring, diagnostic surveillance, and compliance tracking. This is particularly important for chronic conditions such as hypertension and diabetes,” he said.
He, however, observed that Nigeria’s broader healthcare financing system remains weak, with over 70 per cent of healthcare expenditure funded out-of-pocket and fewer than 10 per cent of Nigerians covered by any form of health insurance under the National Health Insurance Authority.
He added that fragmented financing across federal, state, and local levels further limits efficiency and the integration of preventive care.
“There is no uniformity. Funds are fragmented, and schemes operate in silos. This is not helping the system,” he said.
While acknowledging provisions in the National Health Insurance Act, Olusanya said enforcement remains weak and must be strengthened to expand coverage and integrate preventive services more effectively.
He reiterated that Nigeria must deliberately shift its focus towards diagnostics and prevention as part of broader healthcare reform.
“Prevention and diagnostics are not costs; they are investments. If we embed them properly into our healthcare system and financing models, we will reduce catastrophic health spending and improve outcomes for Nigerians,” he said.





